TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding. October 28, 2005